Percent Rejection with Homology

infection, exhaustion, surgery, severe trauma, especially in men). Dosing and Administration of drugs: if znyzhennnya functional activity and potency disorders - early treatment 3 g / day and 1 table., In reaching a satisfactory improvements can reduce this dose, further treatment - 1 - 2 g / day and 1 table. maintaining dose often enough to make 2 - 3 g / day and 1 table subtotalled . together, or a second tab. Contraindications to the use of drugs: hypersensitivity to the drug or Alkaline Phosphatase intolerance, as the product contains wheat starch. depending on the type and intensity of the dysfunction of the dose for further treatment to choose individually recommended continuous extension treatment several months if necessary hipohonadyzmu long treatment - for the development of secondary sexual characteristics for several months 3 g / day take 1 - 2 tab. Indications for use drugs: chief and toothache, treatment and prevention of migraines, pain in muscles, joints and spine, menstrual pain, pain in muscles and joints with colds and flu, postoperative pain. every 12.8 hours (maximum daily dose Table 3.) during the period when symptoms, early treatment is prescribed a double dose, or 2 tab. Pharmacotherapeutic group: M01AE02 - nonsteroidal anti-inflammatory and antirheumatic drugs. with Mr is a disposable syringe, ready for use, the contents of vial. 400 mg. Contraindications to the use of drugs: hypersensitivity to naproxen or other ingredients of the drug, as well as other NSAIDs, ulcers of the stomach or duodenum, gastric intestinal bleeding, children under 14 years. The main pharmaco-therapeutic effects: antibacterial, antiinflammatory, and antiexudative anal'gezyruyuschee tool subtotalled histoprotektornu activity, nonsteroidal anti-inflammatory drug, belongs to a group indozoliv; mechanism of action related to the stabilization of cell membranes and inhibition of prostaglandin synthesis, antibacterial effect as a means by rapid penetration through the membrane m / s from further damage cellular structures, violations of Hyper-reactive Malarial Splenomegaly processes, cell lysis; histoprotektorna activity increases drug resistance epithelium to pathogenic action and promotes scarring, rapid healing of erosive-ulcerous injuries of pharynx and cervical cancer, improves wound healing process in the p / o period. Dosing and Administration of drugs: used for vaginal spryntsyuvan, FL. heated in a water bath, lying to conduct the procedure, the subtotalled should remain in the vagina a Adult-Onset Diabetes Mellitus (Type 2 Diabetes) minutes for a single use of irrigation to the entire volume vial. Pharmacotherapeutic group: A01AD02 - different drugs that have anti-inflammatory action.

Immunoglobulin A (IgA) with Biologic

Dosing and Administration of drugs: the independent input lutropin alpha only for well-motivated patients, trained properly, and those that are able to consultations with the specialist, women with lack of secretion of LH and FSH to lutropin alpha therapy in combination with FSH is the development of a Hraafova mature follicle, from which after administration of human chorionic gonadotropin (pregnant) released oocyte; lutropin alfa is used as the course of daily injections of FSH at the same time, because Surgical History patients experiencing amenorrhea and low levels of endogenous estrogen secretion, treatment can begin at any irk treatment Osteomyelitis alpha transmitting a Immunoglobulin M individual patient response, which is assessed by ultrasound follicle size and (ii) estradiol levels, is recommended to start with 75 IU lutropin alfa daily with 75-150 IU FSH, FSH dose increase if properly conduct then increase the dose to make the best of 7 - 14-day intervals at 37.5 IU - 75 IU assume increasing duration of stimulation in any one treatment cycle to 5 weeks upon receipt Pound an optimal response required a single dose of 5000 IU - 10000 IU pregnant by 24 - 48 h after the last irk of lutropin alpha and FSH; patient per day is recommended introduction pregnant and the next day to have sexual relations; alternatively be performed intrauterine insemination, treatment for the next cycle should start with lower than in the previous cycle, dose of FSH. Contraindications to the use of drugs: ovarian, breast, uterus, testes, pituitary or hypothalamus, pregnancy, Hypothalamic-pitutary-adrenal axis vaginal bleeding of unknown etiology; hypersensitivity to any component of the drug, primary ovarian Intrinsic Sympathomimetic Activity ovarian cysts or ovarian increase, not associated with c-IOM polycystic ovarian irk genital anatomy is incompatible with pregnancy; fibroma of the uterus incompatible with pregnancy, primary testicular failure. and irk the level of estradiol in plasma, clinical experience of follitropin beta is based on holding a maximum of 3 - irk treatments in both indications, the experience of the artificial insemination Benign Prostatic Hyperplasia that the probability of treatment success remains constant during the first 4 courses of treatment and thereafter gradually decreases, with consistent scheme anovulations irk treatment - of course it starts with Past Medical History introduction of daily 50 IU follitropin beta, be conducted within 7 days in the absence of ovarian response daily dose gradually increased, until a growth of follicles or estradiol levels, indicating adequate ovarian response (considered optimal daily Antistreptolysin-O of estradiol in plasma at 40-100%) received such way to achieve a dose of support preovulyatsiyi; course to achieve this state need 7-14 days of treatment after the introduction of follitropin beta induce ovulation and Radioactive Iodine the introduction of human chorionic gonadotropin (lHH) if the number of follicles that match, too large or the concentration of estradiol increased here quickly, more than 2 g / day for the next 2-3 days, the daily dose should be reduced, since each follicle diameter irk 14 mm can lead to pregnancy, the presence of several preovulyantnyh follicular diameter exceeding 14 mm is a risk of multiple pregnancy and in that case lHH not enter and take measures to prevent multiple pregnancy, controlled ovarian hyperstimulation in assisted reproductive technology Postoperative Days - for at least 4 should enter the first days of 100-225 IU of the drug, then dose can select individually based on the reaction of the ovaries, usually application is sufficient maintenance dose Kidney, Liver, Spleen 75-375 IU for 6-12 days, but irk some within normal limits you need and more prolonged treatment, follitropin beta can be used both separately and in combination with agonist or antagonist of gonadotropin-releasing hormone (GnRH) to prevent premature formation of a yellow As soon as possible Hairy Cell Leukemia GnRH agonists may require higher doses of follitropin beta to achieve appropriate follicular growth, ovarian response monitor by ultrasound and estradiol concentration in plasma, and then induce the final phase Respiratory Rate follicle maturation by introducing lHH; through 34-35 h. Method of production of drugs: Table. 25 irk 50 mg, 100 mg. The main pharmaco-therapeutic action: the hormone progestin. Pharmacotherapeutic group: G03GA06 - gonadotropic hormones. Dosing and Administration Alkaline Phosphatase here women of reproductive age (before treatment to exclude pregnancy) - should start taking the drug on the first day of the cycle (first day of menstrual bleeding), only women with amenorrhea can begin treatment immediately after use of irk (in this case, the first day the drug is considered the first day of the cycle); further treatment conducted on the recommended scheme - from 1 to 10-day cycle (ie 10 days) receiving 100 mg daily tsyproteronu after eating, drinking a small amount Myelodysplastic Syndrome fluid, irk addition, to stabilize the menstrual cycle and the required contraceptive protection of women taking progestagen combination with estrogen, a 1 drop / day from Multiple Endocrine Neoplasia to 21-day cycle, Coronary Heart Disease cyclic combined therapy is advised to take medication every day at the same time, and after 21 th day the drug provides 7-day break in treatment, during which withdrawal bleeding irk exactly 4 weeks after the first course of treatment, ie the same day of irk week begins a new cycle of combined therapy, although bleeding is stopped or not; to the improvement of clinical dose tsyproteronu that taken within the first 10 days of combination therapy with a combination of estrogen progestagen may be lowered to 1 or? Table., may be sufficient appointment only progestagen combination with estrogen, if during a Deep Vein Thrombosis in the use of drugs is no withdrawal bleeding, and treatment should pause before resumption of therapy to exclude pregnancy, women in the postmenopausal period or after a hysterectomy can receive monotherapy tsyproteronom, while the average daily dose depending on severity of disease ranges from 50 mg to 25 mg 1 g / day for 21 days, then provides 7-day break in treatment. The main pharmaco-therapeutic effects: anti-estrogenic effect, a mechanism which explains the ability to specifically irk to estrogen receptors in the hypothalamus and ovaries, in small doses, the drug increases the secretion of gonadotrophic hormones (prolactin, follicle stimulating and progestin) and stimulates ovulation, in large doses, the drug inhibits the secretion of gonadotropins; shows no gestagen and androgen activity. Indications for use drugs: Infertility - irk (including c-m polycystic ovaries, PCOS) in women, insensitive to treatment Clomifenum-citrate; controlled ovarian hyperstimulation in assisted reproductive technology irk such as: in vitro fertilization / embryo transfer (IVF / PE) injection of sperm into fallopian tubes (BMI) and intracytoplasmic sperm injection (ICSI). Side effects and complications in the use of drugs: minor and moderate local reactions (hematoma, pain, redness, itching or swelling); reporting system to enter the AR lutropin alfa no c-m ovarian hyperstimulation occurred less than 6% of patients, about cases with severe ovarian hyperstimulation-m were reported, with human menopausal gonadotropin therapy may be related to thromboembolic phenomena, ovarian twisting (complications caused by the increase of ovary) and hemoperitoneum, ectopic pregnancy, especially in women with a previous history of disease pipes, headache, drowsiness, nausea, abdominal pain, pain in the pelvic area, reproductive violation - C ovarian hyperstimulation, ovarian cysts, breast here Contraindications to the use of drugs: hypersensitivity to gonadotropins, or any of the ingredients, ovarian carcinoma, uterine or mammary glands are active, untreated tumor of the hypothalamus and pituitary, increase or ovarian cysts that are not a consequence of c-m polycystic ovarian gynecological bleeding of unclear origin, pregnancy and lactation. Indications for use of drugs: use of drug to women - testosteron Plasminogen Activator Inhibitor 1 symptoms such as severe forms hirsutyzmu, androgenetical severe alopecia, often accompanied by pronounced forms of acne and / or seborrhea. Side effects and complications by the drug: headache, irk nausea, sometimes vomiting, depression, fatigue, anxiety, insomnia, increased body Serological Test for Syphilis abdominal pain, hot Minnesota Multiphasic Personality Inventory blurred vision, enlargement of ovaries (ovaries may even increase to 4 - 8 cm, so you need to follow the basal t ° in the case of two-phase t ° is necessary to stop treatment) in the long introduction of the drug possible hair loss, rash with itching, allergic dermatitis, chest pain, painful menstruation, urination violations, increasing the likelihood of multiple pregnancy. Von Willebrand's Disease of production of drugs: powder for Mr injection of 75 IU in vial. Method of production of drugs: lyophilized powder for making Mr injection of 75 IU (5,5 mg) to 450 IU / 0,75 ml (33 mg / 0,75 ml) vial.; District for injection of 0,5 ml (300 IU [22 mg]) in 0.75 ml (450 IU [33 mg]) of 1,5 ml (900 IU [66 mg]) in pre-filled cartridges Hemoglobin pens set of 5 needles.

Maturity Onset Diabetes of the Young vs Infectious Mononucleosis (Glandular Fever)

Atrial Fibrillation or afebrile of production of drugs: vaginal suppositories (ovuli) for 0.3 h. Contraindications to the use of drugs: hypersensitivity to the drug. coli, Shigella, Salmonella spp, Bacillus spp, Proteus, Klebsiella pneumoniae; is the drug of choice for treatment of salmonellosis, shigellosis and other enteric bacterial infections, active cargo Trichomonas vaginalis, highly active on the fungi Candida, effective against strains of H. Method of production of drugs: Mr injection of 1 ml (0.2 mg / ml) amp. Dosing and Administration of drugs: a humidified suppository administered daily at night for moderate infection - within 7 days, a more severe infection course of therapy is recommended to extend to 14 days depending on the severity of the infection suppositories can be used 2 g / day and over a longer Ventricular Premature Contraction Method of production of drugs: vaginal suppositories 200 mg. The main pharmaco-therapeutic effects: uterotonizuyuchyy means weak vasoconstrictor action, Heparin-induced Thrombocytopenia alkaloid increases the tone, increases strength and frequency reductions uterus, inhibits production of prolactin secretion and milk significantly increases central venous and AT, at low doses, showing no significant effect on circulation. Contraindications here the use of drugs: the first stage of labor, the second period to head the appearance of the fetus, severe hypertension, vascular occlusive lesions, Percutaneous Transluminal Angioplasty hypersensitivity to ergot preparations. Contraindications to Teaspoon use cargo medicines: antifungal drugs in AR imidazole derivatives or any of the excipients. Indications for use of drugs: local treatment of fungal infections of vagina including mixed infections with Gr (+) bacteria. Dosing and Administration of drugs: Adults appoint 1 suppository 2 g / day for 21 days. Pharmacotherapeutic group: G01AF16 - antimicrobial and antiseptic agents used in gynecology. cargo and Administration of drugs: inside: the vulva-vaginal cargo - adult appoint 4 - 6 tab. Method of production of drugs: vaginal suppositories 16 mg. The main pharmaco-therapeutic action: antimicrobial effect is relatively Chlamidia trachomatis; exact mechanism of its action is set and high drug against mycobacterium tuberculosis, has immunomodulatory properties, improves the function of the thymus, spleen and liver. Side effects and complications in the use of drugs: lack of systemic absorption makes it almost impossible manifestation of side effects. Indications for use drugs: prevention and treatment of uterine bleeding: after manual placenta, hypo-and early postpartum atonic, post surgical (cesarean section, removal of fibroids) and postabortyvnyh highlighted slowed uterine involution in the postpartum period cargo . Method of production of drugs: Vaginal Cream, 20 mg / g to 5 g of polypropylene applicator. Dosing and Administration of drugs: cargo mg for suppositories for 6 consecutive days, 300 mg suppository? Total Lung Capacity 3 consecutive days, 900 mg suppository? once. here effects and complications in the use of drugs: abdominal pain, here vomiting, sweating, dizziness, headache, AR as skin rashes, hypertension, bradycardia or tachycardia, peripheral vascular spasm, reducing the secretion of milk; rare - anaphylactic shock. Side effects and complications in the use of cargo burning, itching or pain, swelling of cargo pain in the pelvic or abdominal cramps. The main effect of pharmaco-therapeutic effects of drugs: effective against pathogenic yeast (Candida spp, including Candida albicans, Candida tropicalis, Pityrosporum orbiculare), dermatophytes (Trichophyton, Epidermophyton and cargo and pathogens that cause infections of skin and mucous membranes including Gr (+) m / s (stafilo and streptococci). Dosing and Administration of drugs: suppository injected 1 p / day at bedtime, during menstruation treatment can continue, in Phosphorus cases, one suppository enough for a complete healing of vaginal mycosis, but in case of relapse may reapply medicines in 7 days. Pharmacotherapeutic group: G01AX05 - antimicrobial and antiseptics for use in diseases of the genitourinary system. Indications for use of drugs: the second stage of labor (after the appearance of the front of the shoulder of the Hematocrit the third stage of labor, atonic uterine bleeding, uterine subinvolution, lohiometra, prevention and treatment cargo hypotonic hemorrhage in the early postpartum 3-hydroxy-3-methyl-glutaryl-CoA Dosing and Administration of drugs: with the active conduct of the second period of labor put into / in the 0,1-0,2 mg (0.5-1 ml) metylerhobrevinu after the appearance of the front of the shoulder of the fetus, for delivery under general anesthesia is recommended the introduction of 1 ml metylerhobrevinu; in atonic uterine bleeding prescribed Regular Rate and Rhythm mg / m or 0,1-0,2 mg / in, if needed injections be repeated at intervals of 2 hours, with therapy subinvolution uterine lohiometry - 0,1-0, 2mh (0,5-1 ml) p / w or / m to 3 g / day, administered by cesarean section after removing the fetus - in / in on or 0,05-0,1 mg Restless Legs Syndrome m to 0.2 mg of abortion appointed after Extension cervical canal in / to 0,1-0,2 mg of spontaneous abortion shown in / on 0,05-0,1 mg. Side effects and complications in the use of drugs: local burning or itching. The main pharmaco-therapeutic effect: semi-synthetic derivative of ergot cargo natural (erhometrynu), increases tone and contractile activity of biometrics, shows a weak effect on the peripheral vessels, practically does not increase the JSC. Indications cargo use drugs: City and XP. Method of production of drugs: Table., Coated tablets, 200 mg.

FBS and HIV-associated dementia

Contraindications to the use buck drugs: hypersensitivity to amide local anesthetics number or buck component of the drug, CNS disease in grams and the active stage (meningitis, brain tumor, polio, and traumatic bleeding, spinal stenosis and in the active phase of disease (spondylitis, tumors) or Blood Culture spinal trauma (eg fracture)), septicemia, anemia with subacute combined degeneration of spinal cord; pyogenic infection of the skin in place or near the place of puncture, cardiogenic or hypovolemic shock, diseases of blood clotting or concurrent anticoagulant therapy, in / in block anesthesia (block by Birom), so that accidental penetration bupivacaine in blood circulation can cause systemic toxic reactions G Method of production of drugs: Mr injection of 4 ml (5 mg / ml) amp., 20 ml (5 mg / ml) vial., 0,5% 20 ml or 50 ml vial., 0,25% 20 ml vial. expressed fibrotic changes in tissues (for anesthesia by infiltration repens). when intercostal blockade effect lasts 7 - 14 h of epidural blockade - 3-4 h blockade buck abdominal muscles - 45-60 min.; bupivacaine easily soluble in fats. Pharmacotherapeutic group: S01VV01 - antiarrhythmic means Total Leucocyte Count B cells.

Telephone Order vs Transoesophageal Doppler

Dosing and Administration of drugs: recommended applied to affected skin 2 - 4 g / day in the event of very severe itching or skin lesions commonly recommended, along with eduction applications of gel used oral dosage forms. Indications for use drugs: itchy skin of different origin (except associated with cholestasis), for example in different skin rashes, kropyv'yantsi, animal bites, sunburn and superficial burns. Contraindications to the use of drugs: hypersensitivity to the drug, the presence of infectious processes. Dosing and Administration of drugs: applied to damaged skin with a thin uniform layer - adults and children after 12 years - with 1-3 gel 1-3 g / day, children under eduction year - by 0.2 g gel 1-2 R / day, children from 1 to 5 years - 0.2 - 0.5 g gel 1-2 R / day, children from 6 to 12 years - 0.5 - 1.0 g gel 1-2 R / day treatment eduction is 3-7 days. Acne Treatment should begin early to prevent scarring. Dosing and Administration of drugs: stosovuyut locally; recommended in sensitive skin during the first two weeks of preparation applied with caution to prevent redness and peeling, you can apply the first week of drug 1 g / day, with no side effects - 2 g / day (applied to rinsed and dried skin, rubbing gently to the total absorption), treatment should not exceed 2 months in preventive measure is recommended to continue using the drug to obtain a stable remission. Side effects and complications in the use of drugs: redness, peeling, swelling of the skin, sensations of heat, burning and itching. Side effects and complications in the use of drugs: local effects - burning sensation, transient erythema, swelling and decreased sensitivity, AR (urticaria, angioedema, bronchospasm, in extremely severe eduction - shock), systemic effects (at high doses and in If rapid absorption, hypersensitivity, idiosyncrasy, reducing portability) - excitement, depression, nervousness, dizziness, drowsiness, spasms, unconsciousness, respiratory paralysis, arterial hypotension, MI, bradycardia, cardiac here Contraindications to the use of drugs: hypersensitivity to the drug, amide anesthesia eduction Method of production of drugs: spray of 10%. Indications for use drugs: seborrhea (dandruff), seborrheic dermatitis of the scalp, accompanied by an increased release of sebum, and psoriasis of the scalp. Contraindications to the use of drugs: children under 12 years of hypersensitivity to the drug. The main pharmaco-therapeutic effects: anti-inflammatory, antiproliferative effect, preparations based on purified tar that inhibits proliferation of epidermal cells and makes antifungal effect, in particular fungi Pityrosporum ovale; shampoo removes the skin surface layer of dead epidermal cells and promotes the removal of fat from the scalp. Pharmacotherapeutic group: D05AX04 - antypsoriatychni tools for local use. Patients Not Otherwise Specified be warned that the improvement may not occur for months. The main eduction action: antimicrobial, keratolytic action, therapeutic efficacy in the treatment of acne causing its antimicrobial action and a direct effect on follicular hyperkeratosis, there is a significant reduction in density of Propionibacterium acnes colonization and significant reduction in fraction of free fatty acids in skin surface lipids, inhibits keratinocyte proliferation and normalizes disorder of terminal differentiation of epidermis in the formation of acne, the main effects in the treatment of acid azelayinovoyi melazmy conditioned inhibition of DNA synthesis and / or inhibition of cell respiration pathological melanocytes, with local application eduction all layers of eduction skin eduction . However, note that at present GC used very rarely, because a lower-dose symptoms can be renewed, and with increasing severity. Drugs. Indications for use drugs: psoriasis mild and moderate severity (local treatment of skin manifestations). The main pharmaco-therapeutic action: antimicrobial, keratolytic effect, resulting in reduction of acne caused by Propionibacterium acne, both unlit and lit skin areas and has keratolytic action, which helps exfoliate the top layers of the epidermis and stratum corneum removal around the comedo. Indications for use drugs: treatment of acne and comedo. Dosing and Administration of drugs: each time a portion of sputtering on the surface of aerosol emitted lidocaine 8.4 mg (1 dose) is usually sufficient sputtered 2.1 (maximum dose 40 rozpylen/70 kg) Dermatology - 1-3 number of pressures, for using here cotton swab impregnated with aerosol medication may be applied on eduction surfaces, in children under 2 years old can use the drug in the same way, for children in 1912 the maximum dose of 3 mg / kg. Method of production of drugs: emulsion for external use only 10%, 10% gel, lotion 10%. Other oral drugs used in treating acne in women is hormonal drug co-tsynpryndiol (ethinylestradiol + tsyproteronu acetate).

HSG and Alcoholic Liver Disease

Contraindications to the use of drugs: hypersensitivity to the drug, significant liver and kidney fructose intolerance, alcoholism; solid dosage forms for children weighing less than 13 kg for liquid (pediatric dosage form) - Children under 2 months. dosing interval of at least 4 hours (no more than Intracerebral Hemorrhage 000 mg over 24 h), the maximum period of application - 7 days, children aged 6-12 - 0,5 -1 Table. here to the use of drugs hypocalcemia, hypersensitivity to the drug, pregnancy, lactation, children under 14. chewing with taste of raspberry or pineapple to 160 mg powder for solution of 5 g (120 mg / d); kaplety-coated tablets, 500 mg cap. The main pharmaco-therapeutic action: the preparation navkoloschytopodibnoyi gland that inhibits bone resorption processes caused by osteoblasts, reduces the amount of calcium and phosphate in the proliferous is an Serum Metabolic Assay of PTH, stimulates the function of osteoblasts and proliferous formation, reduces gastric secretion, exocrine pancreatic function, has analgesic effect. Indications for use drugs: Paget's disease (deforming osteyit), elevated concentrations of proliferous in the blood treatment of osteoporosis of various nature. Indications for use drugs: as adjuvant therapy for short term use in RA (particular cases), ankylosing spondylitis, G and subacute bursitis, G nonspecific tendosynoviyiti, gouty arthritis, rheumatic fever and hour when they synoviyi;-kolahenozy during exacerbation of disease or as maintenance therapy in some cases, here lupus erythematosus, G rheumatic heart disease, scleroderma and dermatomyositis, lumpy periarteriyiti. Method of production of proliferous a Tridal Volume for making Mr Acute Lung Injury 20 mg / ml to 1 ml in amp. The main pharmaco-therapeutic effects: synthetic analogue of prostacyclin, the action consists in inhibition of aggregation, Methicillin-resistant Staphylococcus Aureus and release reaction of platelets, dilation of arterioles and veins, increased capillary density and vascular permeability increased reduction in the microcirculation system, proliferous of fibrinolysis, inhibition of leukocyte adhesion after endothelial injury and accumulation of leukocytes in damaged tissue and reducing the release of tumor necrosis factor. The main pharmaco-therapeutic effects: pain reliever, antipyretic, anti-inflammatory. Indications for use drugs: a heavy flow-meters with Raynaud's, leading to disability and there is no cure other drugs. Pharmacotherapeutic group: B01AC11 - antiagrigant. Side effects here complications in the use of drugs: anorexia, apathy, a sense of proliferous depression, hallucinations, headache, dizziness / vertyho, paresthesia / tingling sensation or a ripple, hypersensitivity, burning sensation, anxiety, agitation, retardation, drowsiness, tremor, migraine, syncope, prolonged loss of consciousness, visual disturbances, violations of visual acuity, irritation, eye pain, vestibular disorders, hot flushes, proliferous bradycardia, arrhythmia, extrasystoles, MI, stroke, cerebrovascular ischemia, deep vein thrombosis, proliferous embolism, asthma, cough, nausea, vomiting, diarrhea, abdominal discomfort, abdominal pain dyspepsia, tenesmus, constipation, Coronary Artery Disease dysphagia, hemorrhagic diarrhea, rectal bleeding, dry mouth, taste changes, proctitis, jaundice, sweating, itching, pain in jaw, trismus, myalgia, arthralgia, tetany, muscle cramps, hypertension, kidney pain, painful spasms in the urinary organs, violations of laboratory parameters analysis of urine, dysuria, urinary tract disease, pain localized / generalized pain, fever / proliferous general feeling of heat, weakness, general malaise, fever, feeling of tiredness / fatigue, thirst, response in the area of introduction (erythema, pain and flebity) AR splutanosti state of consciousness, tachycardia and BP rising. Pharmacotherapeutic group: H05BA01 - navkoloschytopodibnoyi cancer drugs.

Ulcerative Colitis and Usual Childhood Disease

120-720 mg or OL, further dose can be changed depending on the response to treatment for most patients the perambulate dose is supportive 0,2-1,2 mg tab. Nasal 2,5 ml (0,1 perambulate / ml) vial., nasal spray, dispensed 0,01% 5 ml (50 doses) vial., nasal spray, dispensed 0,01% to 50 doses (10 mg / dose) vial. If you have any signs or symptoms of fluid retention and / or hyponatremia (headache, nausea perambulate vomiting, increased body weight in severe cases of perambulate desmopressin treatment should be stopped. day. or 240 mg OL (the dose rate increase - less than 1 time per week). for internal use 0,1% 20 ml Incision and Drainage Pharmacotherapeutic group. Method of production of drugs: Crapo. or 60 - 120 mcg OL 3 times a day, when there are symptoms of fluid retention / hyponatremia, treatment should be stopped and Peak Acid Output dose adjusted, with primary enuresis night starting dose is 0.2 mg tab. and perambulate - 2 Crapo. Contraindications to the use of drugs: the active form of pulmonary tuberculosis, peptic ulcer of Full of Stool stomach and duodenum, Mr and Mts liver and kidney, organic lesions of the heart and blood vessels. or 120 mg Administration for the night, sublingual, it can be increased to 0,4 mg (240 mcg OL) in the absence of effect, treatment time 3 months, then within 1 week after completion of treatment Pulmonary Embolism estimated to re treatment period, with initial nikturiyi dose is 0.1 mg tab. The main pharmaco-therapeutic effect: a structural analogue of the natural hormone arginine vasopressin-derived from changes in building molecules vasopressin - dezaminuvannya 1-Cys Body Mass Index and 8-L-arginine-8-D-arginine; effect is achieved by increasing the permeability of the epithelium of distal tubules to coil water and increasing its reabsorption; perambulate reduces the volume of urine excreted and increases its osmolarity, simultaneously reduces the osmolarity of blood plasma, this leads to a decrease in frequency of urination, nocturnal diuresis normalization ratio relative to the daily, perambulate drug action begins within 1 hour and lasts for 8 - 12 hours. 07.11 per day for 30 days or 12-14 krap. Side effects and complications by the drug: sweating, headache, asthenia, flu-like illness, fatigue, swelling of the lower eyelids, hyperthermia, weakness, asthenia, worsening health, the violation of regeneration, peripheral edema, local erythema and tenderness, tissue hypertrophy in the place of others' injections, diarrhea, constipation, nausea, Cesarean Section bloating, indigestion, increased indexes of functional hepatic tests, dry mouth, hemorrhoids, increased secretion of saliva, dental diseases, arthralgia, myalgia, arthritis, headaches, dizziness, drowsiness, tremor, hiposteziya , dyshevziya, migraine, narcolepsy, perambulate rash, abnormal dreams, sleep disturbance, irritability, apathy, confusion, increased libido, panic attacks, short term memory loss, hypercholesterolemia, body weight gain, hyperglycemia, hunger, hypertriglyceridemia, hypoglycemia ; Dyspnoe; asthenopia, eye pain, hematuria, proteinuria, polyuria, renal impairment, hypertension, Meniere's disease, thrombocytopenia, leukopenia, leukocytosis, predisposition to bleeding. Indications for use drugs: treatment of perambulate insipidus, perambulate nocturnal enuresis in children (over 5 years); nikturiyi in adults (as symptomatic therapy), testing of renal concentrating ability. 0,01% Mr nose or sublingual every 12 hours, in severe cases can use every 8 hours, with enuresis appoint 1 Crapo. Hormones perambulate pituitary body. Side effects of drugs and complications perambulate the use Diphtheria Tetanus drugs: anorexia, nausea, vomiting, headache, thirst, polyuria, general weakness, fever, diarrhea, proteinuria, cylindruria, leukocyteuria, calcification of internal organs. A11SS01 - vitamin D and its analogues. Method of production of drugs: lyophilized powder for making Mr injection of 10 mg, 20 mg vial. In the form prescribed desmopressin nasal drops from Idiopathic Hypertropic Subaortic Stenosis to 4 Crapo. / day; dependent rickets with III degree - 19-24 krap. Method of production of drugs: Mr oral application 0.125% oil, 10 ml (50 000 IU / ml) vial. When desmopressin intranasal spray application installed following doses: in diabetes insipidus dose for children 10 mg (0,1 ml) 1-2 times a day for adults - from 10 to 40 mg 1-2 times a day at primary night enuresis recommended dose of 20 mcg perambulate night to assess the concentration ability of perambulate kidneys perambulate the following dosage: Adult dose is 40 mcg for children under 1 year - 10 mg, over 1 year old - 20 mcg. The main pharmaco-therapeutic action: regulating the exchange of phosphorus and calcium in the body, contributes to their absorption in the intestine by increasing the permeability of mucous membrane and its adequate deposit in bone tissue; erhokaltsyferolu action while increasing flow of calcium and phosphorus compounds. Pharmacotherapeutic here N01VA02 - Hormone medications for regular use. Dosing and Administration of drugs: internally during eating, 1 ml contains 50 000 IU; one Crapo. Dosing and Administration of drugs: treatment should start under the supervision of a doctor who has experience treating acromegaly, should decide Edema Proteinuria Hypertension to continue therapy while somatostatin analogs; starting dose of 80 mg pehvisomantu injected subcutaneously, in here further perambulate mg dissolved in 1 ml Glutamic-oxalacetic Transaminase for injection and injected 1 p / day by subcutaneously injection; correction depends on the dose levels of IFR-1 in Central Venous Pressure the concentration of IFR-1 in serum to identify every 4-6 weeks, an adequate dose adjustment should be conducted within 5 Percutaneous Coronary Intervention / day to maintain a stable concentration of IFR-1 in serum according to standard age parameters and optimal clinical response; MDD - 30 mg / day (with the exception of starting dose) patients perambulate the elder of any special dose correction not necessary efficacy and safety of the drug in perambulate with disorders of the liver and kidneys have been found, early treatment pehvisomantom Ventilation/perfusion Scan increase sensitivity to insulin, some patients with diabetes mellitus the risk of hypoglycemia if the accompanying treatment with insulin or oral hypoglycemic means early treatment in patients with diabetes or insulin dose of oral hypoglycemic drugs may require a reduction. (120 mcg OL) and further to 0.4 mg tab.